CDK9-IN-10
CDK9-IN-10 is a potent CDK9 inhibitor. CDK9-IN-10 is the ligand for the PROTAC CDK9 degrader-2 (HY-112811) [1].
Product Specifications
CAS Number
[3542-63-0]
UNSPSC
12352005
Target
CDK; Ligands for Target Protein for PROTAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk9-in-10.html
Purity
98.09
Solubility
DMSO : ≥ 100 mg/mL
Smiles
OC1=C2C(C(C=C(C3=CC=CC=C3)O2)=O)=C(O)C=C1OCC4=CC=CC=C4
Molecular Formula
C22H16O5
Molecular Weight
360.36
References & Citations
[1]Bian J, et al. Discovery of Wogonin-based PROTACs against CDK9 and capable of achieving antitumor activity. Bioorg Chem. 2018 Dec;81:373-381.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
137810 100 µg
CD8a (T-cell Surface Glycoprotein CD8 alpha Chain, T-cell Surface Glycoprotein Lyt-2, Lyt-2, Lyt2) (PE) discontinued, see C2259-28D
Ask
View Details 
VG9C13-01 1 mg
Recombinant Autographa Californica Nuclear Polyhedrosis Virus Major Capsid Protein (P39), N-His and C-Myc
Ask
View Details VG9C13-02 100 µg
Recombinant Autographa Californica Nuclear Polyhedrosis Virus Major Capsid Protein (P39), N-His and C-Myc
Ask
View Details VG9C13-03 20 µg
Recombinant Autographa Californica Nuclear Polyhedrosis Virus Major Capsid Protein (P39), N-His and C-Myc
Ask
View Details 